Copyright: ©Author(s) 2026.
World J Gastroenterol. Apr 21, 2026; 32(15): 116083
Published online Apr 21, 2026. doi: 10.3748/wjg.v32.i15.116083
Published online Apr 21, 2026. doi: 10.3748/wjg.v32.i15.116083
Table 3 Endoscopic techniques and intervention details, mean ± SD/n (%)
| Variable | Non-CAP (n = 139) | CAP-assisted (n = 67) | P value |
| ABS (used) | 87 (65.4) | 55 (90.2) | < 0.001 |
| AST (used) | 85 (63.9) | 43 (70.5) | 0.192 |
| APC (used) | 33 (24.8) | 31 (50.8) | < 0.001 |
| Hemoclips (used) | 66 (49.6) | 15 (24.6) | 0.001 |
| Aethoxysklerol 2% (lauromacrogol) (used) | 4 (3.0) | 7 (11.5) | 0.038 |
| Coagrasper (used) | 10 (7.5) | 3 (4.9) | 0.758 |
| ABS dose (mL) | 6.10 ± 2.24 | 3.16 ± 1.46 | < 0.001 |
| AST dose (mL) | 5.61 ± 1.54 | 5.11 ± 1.76 | 0.141 |
| Aethoxyklerol dose (mL) | 1.50 ± 1.00 | 2.79 ± 1.15 | 0.211 |
| Number of hemostatic techniques | 2.14 ± 0.87 | 2.66 ± 1.00 | < 0.001 |
| Hemostasis failure (yes) | 4 (3.0) | 3 (4.9) | 0.545 |
- Citation: Küçükdemirci Ö, Ayyildiz T, Bas B, Eruzun H, Efe N, Bektas A. Endoscopic transparent cap assisted hemostasis: A multicenter retrospective cohort study. World J Gastroenterol 2026; 32(15): 116083
- URL: https://www.wjgnet.com/1007-9327/full/v32/i15/116083.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i15.116083